Moneta Group Investment Advisors LLC Amgen Inc Transaction History

Moneta Group Investment Advisors LLC

$5.03 Billion
Q4 2023

A detailed history of Moneta Group Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 10,467 shares of AMGN stock, worth $3.25 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

10,467

Previous 10,021 4.45%

Holding current value

$3.25 Million

Previous $2.69 Million 11.92%

% of portfolio

0.06%

Previous 0.06%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$255.7 - $288.46 $114,042 - $128,653	446 Added 4.45%	10,467 $3.01 Million
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $259,537 - $322,223	1,187 Added 13.44%	10,021 $2.69 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $81,636 - $96,533	381 Added 4.51%	8,834 $1.96 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $32,287 - $39,353	-143 Reduced 1.66%	8,453 $2.04 Million
Q4 2022 Feb 16, 2023	BUY	$229.03 - $291.01 $241,626 - $307,015	1,055 Added 13.99%	8,596 $2.26 Million

Q4 2022 Feb 16, 2023	SELL	$229.03 - $291.01 $1.73 Billion - $2.19 Billion	-7,533,470 Reduced 99.9%	7,541 $1.98 Million
Q4 2022 Feb 15, 2023	BUY	$229.03 - $291.01 $1.73 Billion - $2.19 Billion	7,532,031 Added 83875.62%	7,541,011 $1.98 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $53,645 - $60,502	-239 Reduced 2.59%	8,980 $2.02 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $430,504 - $479,076	1,866 Added 25.38%	9,219 $2.24 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $236,592 - $261,733	-1,079 Reduced 12.8%	7,353 $1.78 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $224,535 - $256,960	1,129 Added 15.46%	8,432 $1.9 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $26,958 - $31,584	-127 Reduced 1.71%	7,303 $1.55 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $63,300 - $70,226	-271 Reduced 3.52%	7,430 $1.81 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $970,634 - $1.13 Million	4,374 Added 131.47%	7,701 $1.92 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $157,957 - $188,099	730 Added 28.11%	3,327 $765,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $58,193 - $64,715	-248 Reduced 8.72%	2,597 $660,000
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $109,982 - $134,963	556 Added 24.29%	2,845 $671,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $146,885 - $194,810	-806 Reduced 26.04%	2,289 $464,000
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $13,812 - $17,753	-73 Reduced 2.3%	3,095 $746,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $51,710 - $61,960	297 Added 10.34%	3,168 $613,000
Q2 2019 Aug 16, 2019	SELL	$166.7 - $195.41 $10.5 Million - $12.3 Million	-63,152 Reduced 95.65%	2,871 $529,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $10.5 Million - $12.3 Million	63,107 Added 2164.16%	66,023 $529,000
Q1 2019 May 16, 2019	SELL	$180.87 - $203.88 $118,108 - $133,133	-653 Reduced 18.3%	2,916 $554,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $5,426 - $6,116	30 Added 0.85%	3,569 $554,000
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $24,976 - $29,155	-140 Reduced 3.81%	3,539 $689,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $825,281 - $930,396	-4,454 Reduced 54.76%	3,679 $763,000
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $4.8 Million - $5.39 Million	-28,907 Reduced 78.04%	8,133 $1.5 Million
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $68,080 - $76,469	410 Added 1.12%	37,040 $1.5 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $5.99 Million - $6.72 Million	36,050 Added 6215.52%	36,630 $1.51 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $84,037 - $98,208	496 Added 590.48%	580 $99,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $14,178 - $15,841	84	84 $15,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Account

Moneta Group Investment Advisors LLC Amgen Inc Transaction History